Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
European Urology|July 12, 2014
Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2014
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancerYann Neuzillet, Bas W G van Rhijn, Nadia L Prigoda, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?Richard Walker, Uri Lindner, Alyssa Louis, et al.
Urologic Oncology|June 17, 2021
Characterization and management of NMIBC recurrences after TMT: a matched cohort analysisKhaled Ajib, Mohamad Baker Berjaoui, JaimeOmar Herrera-Caceres, et al.
The Journal of Urology|July 29, 2017
Testosterone Responders to Continuous Androgen Deprivation Therapy Show Considerable Variations in Testosterone Levels on Followup: Implications for Clinical PracticeRashid K Sayyid, Abdallah K Sayyid, Zachary Klaassen, et al.
Journal of the National Cancer Institute|July 13, 2013
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
European Urology|April 5, 2011
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancerAlexandre R Zlotta, Thierry Roumeguere, Cynthia Kuk, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancerKhaled Ajib, Michael C Tjong, Guan Hee Tan, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Pageof 17